Effects of calcium glucarate on the promotion of diethylnitrosamine-initiated altered hepatic foci in rats.
Calcium glucarate (CGT), an inhibitor of beta-glucuronidase, is a potent inhibitor of chemically-induced tumors when administered orally. The present study was undertaken to determine the effects of CGT on the promotion of hepatocarcinogenesis by phenobarbital following initiation with diethylnitrosamine (DENA). Partially hepatectomized, DENA-initiated female Sprague-Dawley rats, previously maintained only on chow diet for 2 months, were supplemented with either 0.05% phenobarbital alone or 0.05% phenobarbital plus 4% dietary CGT, for varying time intervals up to 6 months. Histopathologic evaluation of the liver sections showed that CGT significantly delayed the development of altered hepatic foci (AHF). By the seventh month post-initiation, however, the frequency and severity of changes seen in the livers of experimental animals approximated those of the controls.
Oredipe
O A
OA
Department of Pathology, Ohio State University, Columbus 43210.
Barth
R F
RF
Hanausek-Walaszek
M
M
Sautins
I
I
Walaszek
Z
Z
Webb
T E
TE
D000818:Animals; D002118:Calcium / Q000494:pharmacology; D004032:Diet; D004052:Diethylnitrosamine; D005260:Female; D005937:Glucaric Acid / Q000378:metabolism / Q000494:pharmacology*; D005966:Glucuronidase / Q000037:antagonists & inhibitors*; D008114:Liver Neoplasms, Experimental / Q000139:chemically induced / Q000517:prevention & control*; D011230:Precancerous Conditions / Q000139:chemically induced / Q000517:prevention & control*; D051381:Rats; D013400:Sugar Acids / Q000494:pharmacology*
D013400:Sugar Acids; D004052:Diethylnitrosamine; D005966:Glucuronidase; D005937:Glucaric Acid; D002118:Calcium